Characteristics and outcomes in patients with C. difficile infection (CDI) and inflammatory bowel disease: Bezlotoxumab versus placebo

Category Primary study
JournalGastroenterology
Year 2017
This article has no abstract
Epistemonikos ID: 42725aafc8c529dfd2bf33b19529410d98289fe2
First added on: Feb 08, 2025